Home > Insider Trading > Filing (0001179110-21-005645)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	Services-Business Services, Nec (7389)	465726437

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685833	H Calvin Knowlton	228 Strawbridge Drive Suite 100 Moorestown NJ 08057	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-18	12,000	$40.95	841,360	No	4	S	Direct
Common Stock	Disposition	2021-05-19	10,210	$40.76	831,150	No	4	S	Direct
Common Stock	Disposition	2021-05-19	1,790	$41.20	829,360	No	4	S	Direct
Common Stock	Disposition	2021-05-20	10,000	$40.74	706,908	No	4	S	Indirect	Held by spouse.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	Held by spouse.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	Held by trust for children.
Common Stock	20,000	Indirect	Held by trust for children.

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.38 to $41.33, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2), (3) (4) and (6) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.10 to $41.09, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.12 to $41.30, inclusive.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Orsula Knowlton on May 12, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.34 to $41.33 inclusive.